Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Diluted Average) (2023 - 2025)

Volitionrx (VNRX) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $102.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 16.19% year-over-year to $102.1 million, compared with a TTM value of $102.1 million through Sep 2025, up 16.19%, and an annual FY2024 reading of $86.5 million, up 21.47% over the prior year.
  • Shares Outstanding (Diluted Average) was $102.1 million for Q3 2025 at Volitionrx, up from $99.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $102.1 million in Q3 2025 and bottomed at $71.2 million in Q4 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $88.6 million, with a median of $87.2 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) grew 21.47% in 2024, then grew 16.19% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $71.2 million in 2023, then grew by 21.47% to $86.5 million in 2024, then grew by 18.01% to $102.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for VNRX at $102.1 million in Q3 2025, $99.6 million in Q2 2025, and $96.5 million in Q1 2025.